This study describes a molecular analysis of partial trisomy 14q and partial trisomy 12p in a 5-year-old male child presenting with dysmorphic features, congenital heart disease and global developmental delay. Chromosomal analysis of the patient with GTG bands revealed a 47,XY,+der(14)t(12;14)(p13;q22)mat karyotype; the mother's karyotype was 46,XX,t(12;14)(p13;q22). Further, oligonucleotide array- CGH studies revealed an amplification of 32.3 Mb in the 14q11.1q22.1 region, substantiating partial trisomy 14q and additionally displaying an amplification of ∼1 Mb in the 12p13.3pter region for partial trisomy 12p. This is the first study to demonstrate a novel association of partial trisomies of 14q and 12p due to a 3:1 segregation of a maternal balanced translocation involving chromosomes 12 and 14. Gene ontology studies indicated 5 potential candidate genes in the amplified regions for the observed congenital anomalies.

Keywords:
Array CGH, Balanced translocation, Partial trisomy 12p, Partial trisomy 14q
1.
Alazami AM, Monies D, Meyer BF, Alzahrani F, Hashem M, et al: Congenital disorder of glycosylation IIa: the trouble with diagnosing a dysmorphic inborn error of metabolism. Am J Med Genet A 158A:245-246 (2012).
2.
Allderdice PW, Miller OJ, Miller DA, Breg WR, Gendel E, Zelson C: Familial translocation involving chromosomes 6, 14 and 20 identified by quinacrine fluorescence. Humangenetik 13:205-209 (1971).
3.
Allen TL, Brothman AR, Carey JC, Chance PF: Cytogenetic and molecular analysis in trisomy 12p. Am J Med Genet 63:250-256 (1996).
4.
Almal SH, Padh H: Implications of gene copy-number variation in health and diseases. J Hum Genet 57:6-13 (2012).
5.
Angle B, Yen F, Cole CW: Case of partial trisomy 9p and partial trisomy 14q resulting from a maternal translocation: overlapping manifestations of characteristic phenotypes. Am J Med Genet 84:132-136 (1999).
6.
Aradhya S, Manning MA, Splendore A, Cherry AM: Whole-genome array-CGH identifies novel contiguous gene deletions and duplications associated with developmental delay, mental retardation and dysmorphic features. Am J Med Genet 143A:1431-1441 (2007).
7.
Baris HN, Tan WH, Kimonis VE, Irons MB: Diagnostic utility of array-based comparative genomic hybridization in a clinical setting. Am J Med Genet A 143A:2523-2533 (2007).
8.
Chelly J, Khelfaoui M, Francis F, Chérif B, Bienvenu T: Genetics and pathophysiology of mental retardation. Eur J Hum Genet 14:701-713 (2006).
9.
Chen CP, Lin CC, Chuang CY, Lee CC, Chen WL, et al: Prenatal diagnosis of partial trisomy 12 and partial trisomy 21 due to a 3:1 segregation of maternal reciprocal translocation t(12;21)(p13.3;q21). Prenat Diagn 17:675-680 (1997).
10.
Ching YH, Ghosh TK, Cross SJ, Packham EA, Honeyman L, et al: Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 37:423-428 (2005).
11.
Cohen MM, Ornoy A, Rosenmann A, Kohn G: An inherited translocation t(14;15) (p16;q22) leading to two cases of partial trisomy 15. Ann Genet 18:99-103 (1975).
12.
Dundar M, Uzak A, Saatci C, Akalin H: Partial trisomy 14q due to maternal t(4;14)(p16;q32) in a dysmorphic newborn. Genet Couns 22:287-292 (2011).
13.
Fryns JP, Cassiman JJ, Van den Berghe H: Tertiary partial trisomy 47,XX,+14q-. Humangenetik 24:71-77 (1974).
14.
ISCN (2013): An International System for Human Cytogenetic Nomenclature, Shaffer LG, McGowan-Jordan J, Schmid M (eds) (Karger, Basel 2013).
15.
Kajii T, Ohama K, Ferrier A: Trisomy 14 in spontaneous abortus. Humangenetik 15:265-267 (1972).
16.
Kortüm F, Das S, Flindt M, Morris-Rosendahl DJ, Stefanova I, et al: The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. J Med Genet 48:396-406 (2011).
17.
Liu YH, Xie RG, Zhang XY, Wei SD, He Y, et al: A new partial trisomy 12p with artery catheter vagus, congenital cataracts, external auditory canal and no turbinate. Gene 509:164-167 (2012).
18.
Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215 (1988).
19.
Nakata T, Yokota T, Emi M, Minami S: Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma. Genes Chromosomes Cancer 35:30-37 (2002).
20.
Patnala R, Clements J, Batra J: Candidate gene association studies: a comprehensive guide to useful in silico tools. BMC Genet 14:39 (2013).
21.
Rauch A, Trautmann U, Pfeiffer RA: Clinical and molecular cytogenetic observations in three cases of ‘trisomy 12p syndrome'. Am J Med Genet 63:243-249 (1996).
22.
Salas-Labadía C, Lieberman E, Cruz-Alcívar R, Navarrete-Meneses P, Gómez S, et al: Partial and complete trisomy 14 mosaicism: clinical follow-up, cytogenetic and molecular analysis. Mol Cytogenet 7:65 (2014).
23.
Schinzel A: Catalogue of Unbalanced Chromosomal Aberrations in Man, ed 2 (Walter de Gruyter, Berlin 2001).
24.
Seabright M: A rapid banding technique for human chromosomes. Lancet 2:971-972 (1971).
25.
Segel R, Peter I, Demmer LA, Cowman JM, Hoffman JD, Bianchi DW: The natural history of trisomy 12p. Am J Med Genet A 140:695-703 (2006).
26.
Shashidhar Pai G, Lewandowski RC, Borgaonkar DS: Handbook of Chromosomal Syndromes, pp 214-215 (John Wiley & Sons, New Jersey 2003).
27.
Simpson J, Zellweger H: Partial trisomy 14q- and parental translocation of No.14 chromosome. Report of a case and review of the literature. J Med Genet 14:124-127 (1977).
28.
Smith A, den Dulk G, Elliot G: A severely retarded 18-year-old boy with tertiary partial trisomy 14. J Med Genet 17:230-232 (1980).
29.
Stengel-Rutkowski S, Albert A, Murken JD, Zahn-Messow K, Rodewald A, et al: New chromosomal dysmorphic syndromes. 4. Trisomy 12p. Eur J Pediatr 136:249-262 (1981).
30.
Tekin M, Jackson-Cook C, Pandya A: De novo inverted tandem duplication of the short arm of chromosome 12 in a patient with microblepharon. Am J Med Genet 104:42-46 (2001).
31.
Thevenon J, Callier P, Andrieux J, Delobel B, David A, et al: 12p13.33 microdeletion including ELKS/ERC1, a new locus associated with childhood apraxia of speech. Eur J Hum Genet 21:82-88 (2013).
32.
Tsai AC, Digiovanni M, Walton C, Cotter PD: De novo duplication of the short arm of chromosome 12: dup(12)(p13.1p13.3). Am J Med Genet A 134A:229-230 (2005).
33.
Valkova G, Stefanova M: Reproductive possibilities for balanced translocation (14) carriers in families with partial trisomy of proximal 14q. J Med Genet 30:73-75 (1993).
34.
Zahir F, Firth HV, Baross A, Delaney AD, Eydoux P, et al: Novel deletions of 14q11.2 associated with developmental delay, cognitive impairment and similar minor anomalies in three children. J Med Genet 44:556-561 (2007).
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.